162 related articles for article (PubMed ID: 16208410)
1. Human myeloma cells express the bone regulating gene Runx2/Cbfa1 and produce osteopontin that is involved in angiogenesis in multiple myeloma patients.
Colla S; Morandi F; Lazzaretti M; Rizzato R; Lunghi P; Bonomini S; Mancini C; Pedrazzoni M; Crugnola M; Rizzoli V; Giuliani N
Leukemia; 2005 Dec; 19(12):2166-76. PubMed ID: 16208410
[TBL] [Abstract][Full Text] [Related]
2. Osteopontin is an adhesive factor for myeloma cells and is found in increased levels in plasma from patients with multiple myeloma.
Standal T; Hjorth-Hansen H; Rasmussen T; Dahl IM; Lenhoff S; Brenne AT; Seidel C; Baykov V; Waage A; Børset M; Sundan A; Hjertner O
Haematologica; 2004 Feb; 89(2):174-82. PubMed ID: 15003892
[TBL] [Abstract][Full Text] [Related]
3. The involvement of osteopontin and its receptors in multiple myeloma cell survival, migration and invasion in the murine 5T33MM model.
Caers J; Günthert U; De Raeve H; Van Valckenborgh E; Menu E; Van Riet I; Van Camp B; Vanderkerken K
Br J Haematol; 2006 Feb; 132(4):469-77. PubMed ID: 16412019
[TBL] [Abstract][Full Text] [Related]
4. Role of interleukin 16 in multiple myeloma.
Atanackovic D; Hildebrandt Y; Templin J; Cao Y; Keller C; Panse J; Meyer S; Reinhard H; Bartels K; Lajmi N; Sezer O; Zander AR; Marx AH; Uhlig R; Zustin J; Bokemeyer C; Kröger N
J Natl Cancer Inst; 2012 Jul; 104(13):1005-20. PubMed ID: 22745469
[TBL] [Abstract][Full Text] [Related]
5. Regulation of osteopontin and related proteins in rat CC531 colorectal cancer cells.
Georges R; Adwan H; Zhivkova M; Eyol E; Bergmann F; Berger MR
Int J Oncol; 2010 Aug; 37(2):249-56. PubMed ID: 20596651
[TBL] [Abstract][Full Text] [Related]
6. Myeloma cell-osteoclast interaction enhances angiogenesis together with bone resorption: a role for vascular endothelial cell growth factor and osteopontin.
Tanaka Y; Abe M; Hiasa M; Oda A; Amou H; Nakano A; Takeuchi K; Kitazoe K; Kido S; Inoue D; Moriyama K; Hashimoto T; Ozaki S; Matsumoto T
Clin Cancer Res; 2007 Feb; 13(3):816-23. PubMed ID: 17289872
[TBL] [Abstract][Full Text] [Related]
7. Osteopontin dysregulation and lytic bone lesions in multiple myeloma.
Robbiani DF; Colon K; Ely S; Ely S; Chesi M; Bergsagel PL
Hematol Oncol; 2007 Mar; 25(1):16-20. PubMed ID: 17044113
[TBL] [Abstract][Full Text] [Related]
8. The expression of osteopontin and vascular endothelial growth factor in correlation with angiogenesis in monoclonal gammopathy of undetermined significance and multiple myeloma.
Babarović E; Valković T; Budisavljević I; Balen I; Štifter S; Duletić-Načinović A; Lučin K; Jonjić N
Pathol Res Pract; 2016 Jun; 212(6):509-16. PubMed ID: 26997492
[TBL] [Abstract][Full Text] [Related]
9. Osteopontin, angiogenesis and multiple myeloma.
Cheriyath V; Hussein MA
Leukemia; 2005 Dec; 19(12):2203-5. PubMed ID: 16208409
[No Abstract] [Full Text] [Related]
10. The new tumor-suppressor gene inhibitor of growth family member 4 (ING4) regulates the production of proangiogenic molecules by myeloma cells and suppresses hypoxia-inducible factor-1 alpha (HIF-1alpha) activity: involvement in myeloma-induced angiogenesis.
Colla S; Tagliaferri S; Morandi F; Lunghi P; Donofrio G; Martorana D; Mancini C; Lazzaretti M; Mazzera L; Ravanetti L; Bonomini S; Ferrari L; Miranda C; Ladetto M; Neri TM; Neri A; Greco A; Mangoni M; Bonati A; Rizzoli V; Giuliani N
Blood; 2007 Dec; 110(13):4464-75. PubMed ID: 17848618
[TBL] [Abstract][Full Text] [Related]
11. The RANK/RANK ligand system is involved in interleukin-6 and interleukin-11 up-regulation by human myeloma cells in the bone marrow microenvironment.
Giuliani N; Colla S; Morandi F; Rizzoli V
Haematologica; 2004 Sep; 89(9):1118-23. PubMed ID: 15377473
[TBL] [Abstract][Full Text] [Related]
12. Adenovirus-mediated transfer of siRNA against Runx2/Cbfa1 inhibits the formation of heterotopic ossification in animal model.
Lin L; Chen L; Wang H; Wei X; Fu X; Zhang J; Ma K; Zhou C; Yu C
Biochem Biophys Res Commun; 2006 Oct; 349(2):564-72. PubMed ID: 16949041
[TBL] [Abstract][Full Text] [Related]
13. Myeloma cells block RUNX2/CBFA1 activity in human bone marrow osteoblast progenitors and inhibit osteoblast formation and differentiation.
Giuliani N; Colla S; Morandi F; Lazzaretti M; Sala R; Bonomini S; Grano M; Colucci S; Svaldi M; Rizzoli V
Blood; 2005 Oct; 106(7):2472-83. PubMed ID: 15933061
[TBL] [Abstract][Full Text] [Related]
14. Coexpression of bone sialoprotein (BSP) and the pivotal transcriptional regulator of osteogenesis, Cbfa1/Runx2, in malignant melanoma.
Riminucci M; Corsi A; Peris K; Fisher LW; Chimenti S; Bianco P
Calcif Tissue Int; 2003 Sep; 73(3):281-9. PubMed ID: 14667142
[TBL] [Abstract][Full Text] [Related]
15. Dexamethasone promotes DMP1 mRNA expression by inhibiting negative regulation of Runx2 in multipotential mesenchymal progenitor, ROB-C26.
Mikami Y; Takahashi T; Kato S; Takagi M
Cell Biol Int; 2008 Feb; 32(2):239-46. PubMed ID: 17950631
[TBL] [Abstract][Full Text] [Related]
16. Enhanced production of osteopontin in multiple myeloma: clinical and pathogenic implications.
Saeki Y; Mima T; Ishii T; Ogata A; Kobayashi H; Ohshima S; Ishida T; Tabunoki Y; Kitayama H; Mizuki M; Katada Y; Asaoku H; Kitano M; Nishimoto N; Yoshizaki K; Maeda M; Kon S; Kinoshita N; Uede T; Kawase I
Br J Haematol; 2003 Oct; 123(2):263-70. PubMed ID: 14531907
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional regulation of osteopontin gene in vivo by PEBP2alphaA/CBFA1 and ETS1 in the skeletal tissues.
Sato M; Morii E; Komori T; Kawahata H; Sugimoto M; Terai K; Shimizu H; Yasui T; Ogihara H; Yasui N; Ochi T; Kitamura Y; Ito Y; Nomura S
Oncogene; 1998 Sep; 17(12):1517-25. PubMed ID: 9794229
[TBL] [Abstract][Full Text] [Related]
18. [Link between osteoclastogenesis, angiogenesis and myeloma expansion].
Abe M
Clin Calcium; 2008 Apr; 18(4):473-9. PubMed ID: 18379029
[TBL] [Abstract][Full Text] [Related]
19. High heparanase activity in multiple myeloma is associated with elevated microvessel density.
Kelly T; Miao HQ; Yang Y; Navarro E; Kussie P; Huang Y; MacLeod V; Casciano J; Joseph L; Zhan F; Zangari M; Barlogie B; Shaughnessy J; Sanderson RD
Cancer Res; 2003 Dec; 63(24):8749-56. PubMed ID: 14695190
[TBL] [Abstract][Full Text] [Related]
20. Osteopontin silencing by small interfering RNA suppresses in vitro and in vivo CT26 murine colon adenocarcinoma metastasis.
Wai PY; Mi Z; Guo H; Sarraf-Yazdi S; Gao C; Wei J; Marroquin CE; Clary B; Kuo PC
Carcinogenesis; 2005 Apr; 26(4):741-51. PubMed ID: 15661802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
